Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $324.5700 (-5.28%) ($322.6900 - $340.8400) on Tue. Feb. 13, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.06% (three month average) | RSI | 31 | Latest Price | $324.5700(-5.28%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.9% a day on average for past five trading days. | Weekly Trend | REGN declines -6.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(61%) XLV(51%) IVW(44%) XBI(44%) IWF(43%) | Factors Impacting REGN price | REGN will decline at least -1.03% in a week (0% probabilities). UUP(-10%) VIXM(-8%) TLT(-7%) TIP(-1%) SHY(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.03% (StdDev 2.06%) | Hourly BBV | 0 () | Intraday Trend | -4.8% | | | |
|
Resistance Level | $357.76 | 5 Day Moving Average | $332.17(-2.29%) | 10 Day Moving Average | $338.65(-4.16%) | 20 Day Moving Average | $357.76(-9.28%) | To recent high | -17.8% | To recent low | 0.6% | Market Cap | $34.414b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |